The global technology firm FPT has announced the expansion of its specialized offerings with the launch of MediSight. This AI healthcare framework is engineered to assist pharmaceutical organizations, medical device producers, and healthcare providers in navigating the complexities of digital transformation. By integrating autonomous AI agents and specialized applications, the platform aims to address the growing demand for streamlined clinical workflows and adherence to rigorous regulatory compliance standards.
According to the company, the AI healthcare framework is designed to convert fragmented healthcare data into structured, actionable intelligence. This transition is intended to facilitate faster decision-making processes, enhance governance, and reduce the timelines associated with development in the life sciences sector. The system is built upon the FleziPT AI ecosystem and follows the CASAN AI adoption framework to ensure a structured implementation for global organizations.
Core Components of the MediSight Framework
The architecture of MediSight is divided into three primary segments. The Healthcare Insight Platform (HIP) serves as a cloud-native foundation that supports essential interoperability standards such as HL7 v2, FHIR, CDA, and DICOM. This component is critical for the standardization of clinical terminology and the de-identification of sensitive healthcare data.
Furthermore, the MediSight Crew utilizes autonomous AI agents to manage administrative and clinical workflows, while the MediSight Verse provides applications for clinical trials, medical imaging, and patient engagement. For those operating within life sciences, the emphasis on interoperability is a significant factor as AI adoption continues to grow across research and manufacturing operations.
Security and Global Regulatory Standards
The framework has been developed to meet stringent security requirements, including HIPAA, HITRUST r2, and ISO 27001. This ensures that digital transformation initiatives do not compromise data integrity. The platform is compatible with major cloud environments, allowing for seamless integration with existing infrastructure.
Executive Perspective on AI Integration
Chu Canh Chieu, Vice President and Head of Healthcare and Life Sciences at FPT Software, stated that the next phase of innovation requires systems that actively reason through information rather than just storing it. He noted that MediSight is intended to help organizations reduce manual effort and scale digital solutions more efficiently. By combining autonomous agents with clinical applications, the firm aims to help life sciences enterprises eliminate friction and improve outcomes while maintaining regulatory compliance.
This launch leverages nearly twenty years of experience in serving the medical and pharmaceutical sectors. FPT, which is headquartered in Vietnam and employs over 54,000 people across 30 countries, continues to prioritize the AI healthcare framework as a strategic growth area. The company’s focus remains on transforming how healthcare data is utilized to improve the speed and safety of medical software delivery.
